Nimrodi Nir
Reporting owner on Forms 3, 4 and 5, CIK 1602806.
Nimrodi Nir reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-09-30.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Evogene Ltd. CIK 1574565 | director | 1 | 2026-09-30 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Evogene Ltd. Stock Option (right to buy), derivative | 2026-09-04 | A granted | +10,000 | $0 | 10,000 | Form 4 |
| Evogene Ltd. Stock Option (right to buy), derivative, holding | 5,625 | Form 4 | ||||
| Evogene Ltd. Stock Option (right to buy), derivative, holding | 1,800 | Form 4 | ||||
| Evogene Ltd. Stock Option (right to buy), derivative, holding | 1,800 | Form 4 | ||||
| Evogene Ltd. Stock Option (right to buy), derivative, holding | 1,800 | Form 4 | ||||
| Evogene Ltd. Stock Option (right to buy), derivative, holding | 10,000 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001178913-26-004662 | Evogene Ltd. | 2026-09-30 |